Hedge Funds Are Buying Dynavax Technologies Corporation (DVAX)
Is Dynavax Technologies Corporation (NASDAQ:DVAX) a good investment right now? We check hedge fund and billionaire investor sentiment before delving into hours of research.
Dynavax Technologies Corp (DVAX)
Market is closed
News
- First
- << Previous
- 51 - 60
- Next >>
RA Capital Is Expecting A Breakthrough Cardiovascular Drug From This Biotech
The biotechnology industry is up by more than 50% over the last year, but these towering returns don't come without great risk and volatility.
Peter Kolchinsky's RA Capital Has Been Very Active This Month
Since the beginning of November, Peter Kolchinsky's RA Capital Management has informed the U.S.
This Week's 6 Most Important Hedge Fund Moves
As we approach the nexus of third quarter 13F filings (next week), hedge funds have been very active in 13D and 13G land.
Ra Capital Boosts Exposure in Dynavax to 9.9%
Peter Kolchinsky's Ra Capital Management surged its position in Dynavax Technologies Corporation (NASDAQ:DVAX) to almost 26 million shares, a new filing with the SEC has revealed.
Here is What Hedge Funds Think About Dynavax Technologies Corporation (DVAX)
If you were to ask many market players, hedge funds are seen as useless, outdated financial vehicles of a forgotten age.
Chimera Investment Corporation (CIM), Freeport-McMoRan Copper & Gold Inc. (FCX), Anacor Pharmaceuticals Inc (ANAC): What This $5 Billion Hedge Fund Has Been Buying
The biggest new holdings are Charter Communications and Smithfield Foods. Other new holdings of interest include Chimera Investment Corporation (NYSE:CIM).
Depomed Inc (DEPO): Hedge Funds Are Bearish and Insiders Are Undecided, What Should You Do?
In the eyes of many market players, hedge funds are viewed as delayed, outdated financial vehicles of an era lost to time.
Should You Avoid Orexigen Therapeutics, Inc. (OREX)?
In the financial world, there are a multitude of metrics shareholders can use to watch their holdings. A couple of the most innovative are hedge fund and insider trading movement.
Novo Nordisk A/S (ADR) (NVO), Dynavax Technologies Corporation (DVAX), Merck & Co., Inc. (MRK): Three Biggest FDA Rejections This Year (So Far)
At least the Food and Drug Administration is polite. Rather than use the word "rejection", the agency sends a "complete response letter" when a New Drug Application is turned down.
- First
- << Previous
- 51 - 60
- Next >>
Billionaire Hedge Funds
